Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters

Fig. 6

a Representative flow cytometry data, demonstrating the gating strategy used on PBMC for Treg identification and analysis. FSC-area vs. FSC-height was used for doublet discrimination. A “dump” channel was used to gate out dead cells (LIVE/DEAD fixable viability stain), CD14+ monocytes and CD19+ B cells, and lymphocytes were subsequently selected by FSC vs. SSC. CD4+ T cells were gated on the basis of CD4 vs. CD3 staining, then examined for expression of Ki67 and ICOS. Tregs were identified within the CD4+ T cell population as CD25hiCD127lo and Foxp3+. b Longitudinal empirical data, linear mixed models and estimated means (left, centre and right-hand panels respectively) for Ki67+ and ICOS+ expression on CD4+ T cells, and the Treg proportion of CD4 cells (P-values: * <0.05, ** <0.01, *** <0.001, **** < 0.0001)

Back to article page